Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

August 25, 2020

Blocking tumor ‘signals’ and ‘fuel’

Combining two drugs reduced colorectal cancer cell growth in vitro and in an animal model, suggesting the combination may be a promising treatment for patients.

By Leigh MacMillan
August 13, 2020

Acupressure studied to treat neonatal opioid withdrawal

Researchers from Vanderbilt University Medical Center recently completed a study to create a standardized protocol for using acupressure to treat newborns with opioid withdrawal syndrome.

By Kelsey Herbers
August 13, 2020

Newer targeted therapy prolongs life for lung cancer patients

Patients with ALK-positive non-small cell lung cancer treated with ensartinib fared better and lived longer than those who received crizotinib, according to results of a phase 3 study.

By Tom Wilemon
August 10, 2020

A step toward cancer prevention

A computational technique that combines the effect of multiple genomic variants has the potential to identify high-risk individuals for cancer prevention.

By Bill Snyder
August 6, 2020

Appendix cancer survival in young patients varies by race: study

The first study of appendiceal cancer patterns and survival by race/ethnicity among patients younger than 50 in the U.S. showed survival disparities.

By Leigh MacMillan
August 6, 2020

Davis named senior medical director for VICC Cancer Care Network and Strategy

Nancy Davis, MD, has been named senior medical director for VICC Cancer Care Network and Strategy, a new leadership position at Vanderbilt-Ingram Cancer Center responsible for expanding cancer clinics within and beyond the Middle Tennessee catchment area.

By Tom Wilemon
August 6, 2020

Goff named executive medical director for the VICC Cancer Patient Care Center

Laura Goff, MD, MSCI, associate professor of Medicine, has been named the executive medical director for the Vanderbilt-Ingram Cancer Center (VICC) Cancer Patient Care Center.
By Tom Wilemon
July 28, 2020

Post-transplant complication

Vanderbilt researchers conducted the largest analysis to date of a heart complication in children following stem cell transplant. The findings may help guide screening practices to improve outcomes.
By Leigh MacMillan
July 23, 2020

Cellular antiviral defenses

A cellular RNA quality control mechanism was known to restrict replication of RNA viruses. Vanderbilt researchers have discovered it is also antiviral against DNA viruses.
By Leigh MacMillan
July 16, 2020

Richmond steps down as associate director for Research Education for VICC

After serving 16 years as associate director for Research Education at Vanderbilt-Ingram Cancer Center (VICC), Ann Richmond, PhD, Ingram Professor of Cancer Research, is stepping down from the leadership post.
By Tom Wilemon
July 15, 2020

Two brushes with death. Two life-saving Vanderbilt physicians. Then, two children.

"Vanderbilt will always be a place that we hold dear for everything they have done for us,” says Mary Beth Ballard Murray.
By Matt Batcheldor
June 18, 2020

Probing DNA damage repair

After discovering a new mechanism for DNA damage repair last year, Vanderbilt biochemists now provide direct evidence for how it works.
By Leigh MacMillan
June 18, 2020

Cortez named to VICC research leadership role

David Cortez, PhD, has been named associate director for Basic Science Research at Vanderbilt-Ingram Cancer Center (VICC).
By Tom Wilemon
1 … 13 14 15 16 17 … 55